The pharmaceutical sector is currently undergoing significant changes, primarily due to the increasing integration of artificial intelligence (AI) into its processes. This transformation is particularly evident in the initiatives of companies like AstraZeneca, which are heavily investing in AI to optimize the research and development (R&D) of new drugs. However, this technological advancement is not without challenges, especially for SMEs that need to navigate an increasingly technological and competitive environment. Risks include technological dependency and increasing regulatory requirements.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
